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http://dx.doi.org/10.1016/j.fjs.2012.Summary A previously healthy man experienced a headache and confusion for 3 weeks. A
cranial computerized tomography (CT) scan showed a resolving lobar intracerebral hemor-
rhage (ICH) in the right frontal lobe. A stereotactic aspiration of the ICH was performed to
relieve the mass, and biopsy was reported to only show hematoma. However, the patient
continued to have a persistent headache and unsteady gait even 2 months after surgery. A
further cranial CT scan revealed a hypodense parenchymal lesion involving the whole right
frontal lobe, which was shown by magnetic resonance image as a heterogeneously enhanced
and poorly circumscribed lesion extending into the mesial frontal and subcortical areas. Crani-
otomy was done to excise the lesion, and histopathology revealed glioblastoma multiforme
(GBM). The patient then underwent temozolomide-based concurrent chemoradiotherapy. This
is an unusual case of GBM with intratumoral hemorrhage masquerading as hypertensive lobar
ICH, causing a diagnostic pitfall for spontaneous ICH. For stereotactic aspiration for atypical
spontaneous ICH, targets should include the surrounding hypodense or edematous area.
Copyright ª 2012, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Glioblastoma multiforme (GBM) is the most common
primary malignant brain tumor. Clinical manifestations, Renai Road, Da’an District,
net.net (W.-H. Lin).
ight ª 2012, Taiwan Surgical Asso
08.001and prognosis depend on tumor size and location, its
range of infiltration, involvement of eloquent areas, and
the range of surgical resection. Histopathologic features
include necrosis, microvascular proliferation and hyper-
vascularity, increased cellularity and mitoses, and
microscopic intratumoral hemorrhage, among others.
However, a macroscopic presentation as intracerebral
hemorrhage (ICH) is rare, which is demonstrated in this
case report.ciation. Published by Elsevier Taiwan LLC. All rights reserved.
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A 72-year-old man, without a remarkable medical history,
experienced headache and confusion for 3 weeks. A cranial
computerized tomography (CT) scan performed in a private
community hospital disclosed a resolving ICH in the right
frontal subcortical area with subfalcine herniation
(Fig. 1B). Stereotactic aspiration of 30 mL of liquefied blood
clot was done to relieve the mass effect (Fig. 1C). The
biopsy only showed hematomas.
However, the patient had persistent headache and
progressively unsteady gait even 2 months after the oper-
ation. Neurologic examinations performed in our hospital
demonstrated a disorientation state (Glasgow Coma Scale
(GCS) E4M6V4), left hemiparesis [medical research council
(MRC) grade 4/5 of both upper and lower limbs], and
a Babinski sign on the left. Other laboratory studies were
normal. A follow-up cranial CT revealed a hypodense
change in the whole right frontal lobe (Fig. 1D), and an MRIFigure 1 (A) Cranial CT 7 months before diagnosis of GBM. The
diagnosis of GBM. There was a resolving right frontal subcortical IC
Postoperative CT after stereotactic aspiration of the ICH. Procedu
(arrow). (D) Cranial CT 2 months after stereotactic aspiration. Diff
(star), and a mass effect can also be seen (arrow, subfalcine h
enhanced lesion with an irregular margin in the right mesial frontal
multiforme; ICHZ intracerebral hemorrhage; MRIZmagnetic resowith gadolinium enhancement demonstrated a heteroge-
neously enhanced lesion with irregular margin in the right
mesial frontal and subcortical areas (Fig. 1E and F). Imaging
differential diagnoses included a glioma or infectious
process following the previous operation; therefore,
a craniotomy was performed to excise the lesion. Histopa-
thology showed GBM (Fig. 2). The patient then underwent
temozolomide (TMZ)-based concurrent chemoradiotherapy
(CCRT) in accordance with Stupp’s protocol,1 and he has
been followed up as an outpatient regularly for more than 6
months.3. Discussion
Microscopic hemorrhage is frequently found in surgical
tumor specimens of primary or metastatic malignant brain
tumors with reported rates of 9%e15%, but a macroscopic
intratumoral hemorrhage large enough to cause clinicalre was no identifiable lesion. (B) Cranial CT 2 months before
H (arrow) with perifocal edema and subfalcine herniation. (C)
res were performed by targeting the center of the hematoma
use hypodense changes in the right frontal lobe were observed
erniation). (E, F) Brain MRI demonstrated a heterogeneously
area (arrow). CTZ computed tomography; GBMZ glioblastoma
nance imaging.
Figure 2 (A) Tumor cells arranged in solid sheets showing high cellularity, necrosis, and microvascular proliferation (100);
(B) the tumor cells are characterized by pleomorphism, occasionally prominent nucleoli, and frequent mitotic figures (400); (C)
the tumor cells are positive for glial fibrillary acidic protein (GFAP) immunochemical stain (400); (D) the microvascular prolif-
erations (arrows) are outlined by CD34 immunochemical stain (100).
Glioblastoma multiforme 185symptoms or detected by imaging study is relatively rare.2
A retrospective study of macroscopic intratumoral hemor-
rhage showed that only 2.4% of patients with brain tumors
(either primary or metastatic) were found to harbor
radiographically identifiable ICH associated with intra-
tumoral bleeding.3,4 Among those reported cases of brain
tumor-related ICH; GBM was the second leading cause (30%
of cases) following metastatic carcinomas (36% of cases).4,5
As regards the various causes of spontaneous ICH, brain
tumor accounts for only 0.8e7.4% of cases,3 and it follows
hypertension, vascular malformation, and amyloid
angiopathy.2
Clinical diagnosis can become difficult when GBM has
presentations similar to those of spontaneous hypertensive
ICH. Several GBM cases have been reported to masquerade
as traumatic ICH, intraventricular hemorrhage (IVH), or
arteriovenous malformation (AVM).6e10 On CT scans, when
the high-density lesions representing ICH are surrounded by
disproportionately diffuse brain edema, it is essential
to perform an additional imaging studies with contrast
enhancement either by CT or MRI for excluding unusual
causes of hemorrhage.5 Detecting the changes of molecular
signal intensity for abnormal parenchyma by magnetic
resonance spectroscopy (MRS) is an alternative to explore
underlying malignancy. However, the contrast enhance-
ment is frequently hindered by the hematoma, and
patients with acute neurologic deficits and signs of mass
effects are usually unable to tolerate MRI scan and
MRS without appropriate sedation.2 In these situations,
biopsies of brain tissue surrounding the hematoma would
be advised.Minimally invasive surgery for evacuation of ICH, such as
stereotactic aspiration and endoscopy, has the advantage
of minimizing iatrogenic brain damage, reducing glutamate
content, blood-brain barrier permeability, and water
content in brain tissues surrounding the hematoma;
therefore, it is a popular treatment modality for ICH among
neurosurgeons. Minimally invasive stereotactic puncture
and thrombolysis therapy developed in 1997 have been
shown to be safe, with fewer complications and a trend
toward improved short-term and long-term outcomes for
ICH evacuation.11e13 In this case report, although stereo-
tactic procedures removed the hematoma without causing
untoward brain injury, the diagnosis of GBM was delayed by
2 months because of missing the biopsy targets in the
perifocal edematous area. Therefore, GBM confounded
with ICH could be a diagnostic pitfall.
In conclusion, for ICH requiring surgical treatment either
by conventional or minimally invasive methods, histopath-
ologic investigation of edematous area surrounding the
hematoma is recommended, especially in cases with
disproportionately edematous parenchyma and atypical
image presentations of hypertensive ICH. However, inade-
quate sampling is a major concern in stereotactic biopsy
and needs to be redressed. Sampling targets must include
all the suspicious foci revealed by image studies.Acknowledgments
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